結核菌の世界市場レポート (2025年)

結核菌の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.2％で45億7,000万米ドルに成長します。予測期間中の成長は、世界の結核の有病率の増加、薬剤耐性結核の世界の発生率の上昇、結核の感染と予防に関する意識の高まり、結核撲滅に向けた政府の取り組みと資金提供、結核治療に焦点を当てた研究開発の増加などが牽引するとみられます。予測期間における主な動向としては、結核診断技術の発展、迅速な結核検査法の利用可能性、新しい結核ワクチンの導入、多剤耐性結核に対する新しい薬物レジメンの開発、結核薬製剤の技術革新などが挙げられます。

結核菌市場の成長は、研究開発への投資の増加によって牽引されると予想されます。研究開発（R&D）には、体系的な調査や実験を通じて新しい知識を創造したり、既存の製品やサービス、技術を改良したりすることが含まれます。研究開発投資の増加は、急速な技術進歩に後押しされ、世界市場で競争力を維持するための絶え間ないイノベーションの必要性を生み出しています。研究開発は、現在の治療法に対する耐性を克服できる新薬候補を発見することにより、治療効果と患者の転帰を向上させ、結核菌治療に貢献します。例えば、2024年3月、英国政府は、中低所得国における結核の診断と治療を改善するための革新的な戦略を支援することを目的とした結核REACHプログラムに対して、500万米ドル（400万英ポンド）の資金援助を行うことを発表しました。このプログラムにより、50万人にヘルスケアが提供され、3万7,000人の結核が発見され、1万5,000人以上の命が救われる可能性があります。その結果、研究開発への投資が増加し、結核菌市場の成長を牽引することになります。

結核菌市場の各企業は、より迅速で正確な診断を提供するため、自動結核検査などの先進ソリューションの開発に注力しています。自動化された結核検査は、自動化されたシステムと高度な技術を使用し、迅速かつ正確に結核菌と薬剤耐性を検出する診断ツールであり、人の介入は最小限に抑えられています。例えば、2025年4月、米国のバイオテクノロジー企業であるRevvity Inc.は、米国食品医薬品局（FDA）がオートピュア2400リキッドハンドリングプラットフォームとT-SPOT結核検査を承認したと発表しました。オートピュア2400プラットフォームとT-SPOT.TB検査の統合は、精度を維持しながら大量処理を可能にすることで、自動結核検査を改善します。このプラットフォームは、リキッドハンドリング技術と磁気細胞分離技術を組み合わせ、1回の検査で最大24検体を検査し、検査1日目を3.5時間以内に完了し、ユーザーの関与は最小限に抑えられます。T-SPOT.TB検査は、WHOによって唯一のELISPOTベースのIGRAとして認められており、不確定な結果が少なく再現性のある結果を保証し、再検査の必要性を減らし、免疫不全患者に対して信頼性の高い性能を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場のマクロ経済シナリオ：金利・インフレ・地政学・貿易戦争・関税・コロナ禍と回復が市場に及ぼす影響を含む

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の結核菌市場：PESTEL分析（政治・社会・技術・環境・法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の結核菌市場：成長率分析
• 世界の結核菌の市場規模・成長率：実績値、2019～2024年
• 世界の結核菌の市場規模・成長率：予測値、2024～2029年、2034年
• 世界の結核菌市場：総有効市場（TAM）

第6章 市場セグメンテーション

• 世界の結核菌市場：製品種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 装置
• 試薬・消耗品
• ソフトウェア・ソリューション
• 世界の結核菌市場：診断法別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 培養ベース診断法
• 分子診断
• 免疫学的検査
• 世界の結核菌市場：投与経路別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 経口薬
• 注射剤
• 世界の結核菌市場：エンドユーザー別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 病院
• 診断検査室
• 研究機関
• 世界の結核菌市場：装置の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 診断機器
• 検出機器
• 分子診断機器
• 結核培養システム
• 世界の結核菌市場：試薬・消耗品の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• ポリメラーゼ連鎖反応試薬（PCR）
• 結核培養培地
• 抗原キット
• テストストリップ
• 結核診断キット
• 世界の結核菌市場：ソフトウェア・ソリューションの種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 検査情報管理システム（LIMS）
• 診断ソフトウェア
• データ管理ソフトウェア
• 結核診断のための遠隔医療ソリューション

第7章 地域別・国別の分析

• 世界の結核菌市場：地域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 世界の結核菌市場：国別、実績値・予測値、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 結核菌市場：競合情勢
• 結核菌市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd.（概要、製品・サービス、戦略、財務分析）
  • Thermo Fisher Scientific Inc.（概要、製品・サービス、戦略、財務分析）
  • Abbott Laboratories（概要、製品・サービス、戦略、財務分析）
  • Novartis AG（概要、製品・サービス、戦略、財務分析）
  • Becton Dickinson and Company（概要、製品・サービス、戦略、財務分析）

第31章 その他の大手企業と革新的企業

• Viatris Inc.
• Macleods Pharmaceuticals Limited
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• QIAGEN N.V.
• Lupin Limited
• Zydus Cadila Healthcare Limited
• Cepheid Inc.
• Serum Institute of India Pvt. Ltd.
• Oxford Immunotec USA Inc.
• Panacea Biotec Limited
• International AIDS Vaccine Initiative Inc.
• HiMedia Laboratories Private Limited
• Akonni Biosystems Inc.

第32章 世界市場：競合ベンチマーキング・ダッシュボード

第33章 主要な企業合併・買収 (M&A)

第34章 最近の市場動向

第35章 市場の潜在力の高い国・部門と戦略

• 結核菌市場：最新機会を提供する国（2029年）
• 結核菌市場：最新機会を提供する部門（2029年）
• 結核菌市場：成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競争戦略

第36章 付録

Mycobacterium tuberculosis is a slow-growing, rod-shaped bacterium that primarily targets the lungs, although it can also affect other body parts. It is the pathogen responsible for tuberculosis (TB), a contagious disease transmitted through airborne droplets when an infected person coughs, sneezes, or speaks. The bacterium has a distinct, waxy cell wall made of mycolic acid, which provides resistance to drying and helps it persist in the environment.

The primary product types associated with Mycobacterium tuberculosis include instruments, reagents and consumables, and software solutions. Instruments refer to the medical devices and equipment used for diagnosing and researching TB. Diagnosis can be achieved through various techniques, such as culture-based methods, molecular testing, and immunological assays, with administration routes being either oral or injectable. These products are used by various end users, including hospitals, diagnostic labs, and research institutions.

The mycobacterium tuberculosis market research report is one of a series of new reports from The Business Research Company that provides mycobacterium tuberculosis market statistics, including mycobacterium tuberculosis industry global market size, regional shares, competitors with a mycobacterium tuberculosis market share, detailed mycobacterium tuberculosis market segments, market trends and opportunities, and any further data you may need to thrive in the mycobacterium tuberculosis industry. This mycobacterium tuberculosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mycobacterium tuberculosis market size has grown strongly in recent years. It will grow from $3.54 billion in 2024 to $3.74 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to the rising number of TB cases in high-burden countries, increased funding from international organizations, the expansion of TB screening programs, a higher incidence of TB-HIV co-infections, and the growth in global travel and migration, which have contributed to the spread of TB.

The mycobacterium tuberculosis market size is expected to see strong growth in the next few years. It will grow to $4.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth during the forecast period is expected to be driven by the increasing prevalence of TB worldwide, the rising global incidence of drug-resistant TB, heightened awareness about TB transmission and prevention, government initiatives and funding for TB elimination, and increased research and development efforts focused on TB treatment. Key trends in the forecast period include advances in TB diagnostic technologies, the availability of rapid TB testing methods, the introduction of new TB vaccines, the development of new drug regimens for multidrug-resistant TB, and technological innovations in TB drug formulation.

The growth of the mycobacterium tuberculosis market is expected to be driven by increased investments in research and development. Research and development (R&D) involves the creation of new knowledge or the improvement of existing products, services, or technologies through systematic investigation and experimentation. The rising investment in R&D is fueled by rapid technological advancements, creating the need for constant innovation to remain competitive in the global market. R&D contributes to mycobacterium tuberculosis treatment by discovering novel drug candidates capable of overcoming resistance to current therapies, thus enhancing treatment efficacy and patient outcomes. For example, in March 2024, the UK government announced a $5 million (£4 million) funding boost for the TB REACH program, aimed at supporting innovative strategies for improving tuberculosis diagnosis and treatment in low- and middle-income countries. This initiative will provide healthcare to 500,000 people, help detect TB in 37,000 individuals, and potentially save more than 15,000 lives. As a result, the increased investment in R&D is set to drive the growth of the mycobacterium tuberculosis market.

Companies in the mycobacterium tuberculosis market are focusing on developing advanced solutions such as automated tuberculosis tests to provide faster, more accurate diagnoses. Automated tuberculosis tests are diagnostic tools that use automated systems and advanced technologies to rapidly and accurately detect Mycobacterium tuberculosis and drug resistance, with minimal human intervention. For instance, in April 2025, Revvity Inc., a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) approved the Auto-Pure 2400 liquid handling platform with the T-SPOT TB test. The integration of the Auto-Pure 2400 platform with the T-SPOT.TB test improves automated tuberculosis testing by enabling higher-volume processing while maintaining accuracy. This platform combines liquid handling and magnetic cell isolation technologies, testing up to 24 samples per run, completing Day 1 of testing in under 3.5 hours, and requiring minimal user involvement. The T-SPOT.TB test, recognized by the WHO as the only ELISPOT-based IGRA, ensures reproducible results with fewer indeterminate outcomes, reduces the need for repeat testing, and provides reliable performance for immunocompromised patients.

In November 2023, Becton Dickinson and Company (BD), a US-based provider of tuberculosis diagnostics, collaborated with Bio Farma to help Indonesia eliminate the spread of tuberculosis. This partnership aims to enhance access to BD's innovative TB diagnostics portfolio and improve the TB solutions supply chain in Indonesia. It also offers Bio Farma the opportunity to deepen its expertise in the development of diagnostic kits. Bio Farma is an Indonesia-based manufacturer of tuberculosis vaccines.

Major players in the mycobacterium tuberculosis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Macleods Pharmaceuticals Limited, bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Lupin Limited, Zydus Cadila Healthcare Limited, Cepheid Inc., Serum Institute of India Pvt. Ltd., Oxford Immunotec USA Inc., Panacea Biotec Limited, International AIDS Vaccine Initiative Inc., HiMedia Laboratories Private Limited, and Akonni Biosystems Inc.

North America was the largest region in the mycobacterium tuberculosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mycobacterium tuberculosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mycobacterium tuberculosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mycobacterium tuberculosis market consists of revenues earned by entities by providing services such as tuberculosis strain typing and genotyping services, contract research services, biorepository services, and genomic sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mycobacterium tuberculosis market also includes sales of diagnostic kits, antibodies, antigens, recombinant proteins, nucleic acid extraction kits, and biosafety equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mycobacterium Tuberculosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mycobacterium tuberculosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mycobacterium tuberculosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mycobacterium tuberculosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software Solutions
• 2) By Diagnostic Method: Culture-Based Methods; Molecular Diagnosis; Immunological Tests
• 3) By Route Of Administration: Oral; Injectable
• 4) By End User: Hospitals; Diagnostic Laboratories; Research Institutions
• Subsegments:
• 1) By Instruments: Diagnostic Instruments; Detection Instruments; Molecular Diagnostic Instruments; Tuberculosis Culture Systems
• 2) By Reagents And Consumables: Polymerase Chain Reaction Reagents; Tuberculosis Culture Media; Antigen Kits; Test Strips; Tuberculosis Diagnostic Kits
• 3) By Software Solutions: Laboratory Information Management Systems (LIMS); Diagnostic Software; Data Management Software; Telemedicine Solutions for TB Diagnosis
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mycobacterium Tuberculosis Market Characteristics

3. Mycobacterium Tuberculosis Market Trends And Strategies

4. Mycobacterium Tuberculosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Mycobacterium Tuberculosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Mycobacterium Tuberculosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Mycobacterium Tuberculosis Market Growth Rate Analysis
• 5.4. Global Mycobacterium Tuberculosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Mycobacterium Tuberculosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Mycobacterium Tuberculosis Total Addressable Market (TAM)

6. Mycobacterium Tuberculosis Market Segmentation

• 6.1. Global Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents And Consumables
• Software Solutions
• 6.2. Global Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Culture-Based Methods
• Molecular Diagnosis
• Immunological Tests
• 6.3. Global Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• 6.4. Global Mycobacterium Tuberculosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Research Institutions
• 6.5. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Instruments
• Detection Instruments
• Molecular Diagnostic Instruments
• Tuberculosis Culture Systems
• 6.6. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction Reagents
• Tuberculosis Culture Media
• Antigen Kits
• Test Strips
• Tuberculosis Diagnostic Kits
• 6.7. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Information Management Systems (LIMS)
• Diagnostic Software
• Data Management Software
• Telemedicine Solutions for TB Diagnosis

7. Mycobacterium Tuberculosis Market Regional And Country Analysis

• 7.1. Global Mycobacterium Tuberculosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Mycobacterium Tuberculosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mycobacterium Tuberculosis Market

• 8.1. Asia-Pacific Mycobacterium Tuberculosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mycobacterium Tuberculosis Market

• 9.1. China Mycobacterium Tuberculosis Market Overview
• 9.2. China Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mycobacterium Tuberculosis Market

• 10.1. India Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mycobacterium Tuberculosis Market

• 11.1. Japan Mycobacterium Tuberculosis Market Overview
• 11.2. Japan Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mycobacterium Tuberculosis Market

• 12.1. Australia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mycobacterium Tuberculosis Market

• 13.1. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mycobacterium Tuberculosis Market

• 14.1. South Korea Mycobacterium Tuberculosis Market Overview
• 14.2. South Korea Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mycobacterium Tuberculosis Market

• 15.1. Western Europe Mycobacterium Tuberculosis Market Overview
• 15.2. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mycobacterium Tuberculosis Market

• 16.1. UK Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mycobacterium Tuberculosis Market

• 17.1. Germany Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mycobacterium Tuberculosis Market

• 18.1. France Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mycobacterium Tuberculosis Market

• 19.1. Italy Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mycobacterium Tuberculosis Market

• 20.1. Spain Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mycobacterium Tuberculosis Market

• 21.1. Eastern Europe Mycobacterium Tuberculosis Market Overview
• 21.2. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mycobacterium Tuberculosis Market

• 22.1. Russia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mycobacterium Tuberculosis Market

• 23.1. North America Mycobacterium Tuberculosis Market Overview
• 23.2. North America Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mycobacterium Tuberculosis Market

• 24.1. USA Mycobacterium Tuberculosis Market Overview
• 24.2. USA Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mycobacterium Tuberculosis Market

• 25.1. Canada Mycobacterium Tuberculosis Market Overview
• 25.2. Canada Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mycobacterium Tuberculosis Market

• 26.1. South America Mycobacterium Tuberculosis Market Overview
• 26.2. South America Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mycobacterium Tuberculosis Market

• 27.1. Brazil Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mycobacterium Tuberculosis Market

• 28.1. Middle East Mycobacterium Tuberculosis Market Overview
• 28.2. Middle East Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mycobacterium Tuberculosis Market

• 29.1. Africa Mycobacterium Tuberculosis Market Overview
• 29.2. Africa Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mycobacterium Tuberculosis Market Competitive Landscape And Company Profiles

• 30.1. Mycobacterium Tuberculosis Market Competitive Landscape
• 30.2. Mycobacterium Tuberculosis Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Mycobacterium Tuberculosis Market Other Major And Innovative Companies

• 31.1. Viatris Inc.
• 31.2. Macleods Pharmaceuticals Limited
• 31.3. bioMerieux SA
• 31.4. Bio-Rad Laboratories Inc.
• 31.5. Bruker Corporation
• 31.6. QIAGEN N.V.
• 31.7. Lupin Limited
• 31.8. Zydus Cadila Healthcare Limited
• 31.9. Cepheid Inc.
• 31.10. Serum Institute of India Pvt. Ltd.
• 31.11. Oxford Immunotec USA Inc.
• 31.12. Panacea Biotec Limited
• 31.13. International AIDS Vaccine Initiative Inc.
• 31.14. HiMedia Laboratories Private Limited
• 31.15. Akonni Biosystems Inc.

32. Global Mycobacterium Tuberculosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mycobacterium Tuberculosis Market

34. Recent Developments In The Mycobacterium Tuberculosis Market

35. Mycobacterium Tuberculosis Market High Potential Countries, Segments and Strategies

• 35.1 Mycobacterium Tuberculosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Mycobacterium Tuberculosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Mycobacterium Tuberculosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer